GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (NAS:AXDX) » Definitions » E10

Accelerate Diagnostics (Accelerate Diagnostics) E10 : $-13.77 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Accelerate Diagnostics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Accelerate Diagnostics's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.740. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-13.77 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -8.90% per year. During the past 5 years, the average E10 Growth Rate was -13.80% per year. During the past 10 years, the average E10 Growth Rate was -21.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Accelerate Diagnostics was 6.80% per year. The lowest was -49.60% per year. And the median was -23.50% per year.

As of today (2024-06-04), Accelerate Diagnostics's current stock price is $1.16. Accelerate Diagnostics's E10 for the quarter that ended in Mar. 2024 was $-13.77. Accelerate Diagnostics's Shiller PE Ratio of today is .


Accelerate Diagnostics E10 Historical Data

The historical data trend for Accelerate Diagnostics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics E10 Chart

Accelerate Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.84 -10.54 -12.20 -13.17 -13.60

Accelerate Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.44 -13.76 -13.74 -13.60 -13.77

Competitive Comparison of Accelerate Diagnostics's E10

For the Medical Devices subindustry, Accelerate Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Shiller PE Ratio falls into.



Accelerate Diagnostics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Accelerate Diagnostics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.74/131.7762*131.7762
=-0.740

Current CPI (Mar. 2024) = 131.7762.

Accelerate Diagnostics Quarterly Data

per share eps CPI Adj_EPS
201406 -1.900 100.560 -2.490
201409 -2.000 100.428 -2.624
201412 -2.000 99.070 -2.660
201503 -2.000 99.621 -2.646
201506 -2.700 100.684 -3.534
201509 -2.500 100.392 -3.282
201512 -2.900 99.792 -3.829
201603 -2.900 100.470 -3.804
201606 -3.500 101.688 -4.536
201609 -3.400 101.861 -4.399
201612 -3.100 101.863 -4.010
201703 -2.700 102.862 -3.459
201706 -3.100 103.349 -3.953
201709 -3.100 104.136 -3.923
201712 -2.900 104.011 -3.674
201803 -3.700 105.290 -4.631
201806 -4.300 106.317 -5.330
201809 -4.100 106.507 -5.073
201812 -4.100 105.998 -5.097
201903 -4.000 107.251 -4.915
201906 -3.800 108.070 -4.634
201909 -3.700 108.329 -4.501
201912 -3.900 108.420 -4.740
202003 -3.900 108.902 -4.719
202006 -3.500 108.767 -4.240
202009 -3.300 109.815 -3.960
202012 -3.300 109.897 -3.957
202103 -4.100 111.754 -4.835
202106 -3.600 114.631 -4.138
202109 -1.500 115.734 -1.708
202112 -3.490 117.630 -3.910
202203 -2.000 121.301 -2.173
202206 -2.430 125.017 -2.561
202209 -1.830 125.227 -1.926
202212 -1.400 125.222 -1.473
202303 -1.710 127.348 -1.769
202306 -2.970 128.729 -3.040
202309 0.060 129.860 0.061
202312 -0.810 129.419 -0.825
202403 -0.740 131.776 -0.740

Add all the adjusted EPS together and divide 10 will get our e10.


Accelerate Diagnostics  (NAS:AXDX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Accelerate Diagnostics E10 Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerate Diagnostics (Accelerate Diagnostics) Business Description

Traded in Other Exchanges
Address
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Executives
David Patience officer: Chief Financial Officer C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 240, TUCSON AZ 85714
Jack Phillips director, officer: PRESIDENT AND CEO 11731 YALE DR, CARMEL IN 46032
Larry Michael Mertz officer: Chief Technology Officer 3950 S. COUNTRY CLUB ROAD, TUCSON AZ 85714
Marran H. Ogilvie director 599 LEXINGTON AVENUE, NEW YORK NY 10022
Jennifer Regan director C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Mark S. Black director 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Steven Reichling officer: CFO 7000 NORTH BROADWAY, BUILDING 3-307, DENVER CO 80221
Ron Price officer: SVP & HEAD OF COM OPS AMERICAS 3950 SOUTH COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Wayne Burris director 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Hany Massarany director 1910 INNOVATION PARK DR, TUCSON AZ 85737
Jack W Schuler director, 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Mark C Miller director C/O STERICYCLE INC., 28161 N KEITH DRIVE, LAKE FOREST IL 60045
Ten Brink Frank Jm director C/O STERICYCLE INC, 28161 N KEITH DR, LAKE FOREST IL 60045
Charles M Watts director 3950 SOUTH COUNTRY CLUB, SUITE 470, TUCSON AZ 85714
Louise Francesconi director 870 WINTER STREET, WALTHAM MA 02451

Accelerate Diagnostics (Accelerate Diagnostics) Headlines

From GuruFocus

Insider Alert: An Insider Just Sold Accelerate Diagnostics Inc Shares

By GuruFocus Research GuruFocus Editor 05-18-2023